Latest News

Cardiovascular diseases such as strokes and heart attacks are the most common cause of death worldwide, killing over 18 million people every year. A team of researchers from the Karlsruhe Institute of Technology (KIT), with the collaboration of two DZHK scientists, has now...

The European Research Council (ERC) has announced the names of 255 outstanding researcher leaders in Europe set to be awarded ERC Advanced Grants: Professor Alessandra Moretti works in Munich and is a Principal Investigator at the DZHK. She will receive one of the grants of up to...

An analysis of the biomolecule substudy of the EAST - AFNET 4 study revealed that biomolecule concentrations in the blood of people with atrial fibrillation can be used to identify patients at high and low cardiovascular risk. The results were presented today by DZHK scientist...

Numerous DZHK scientists received prizes and awards at the 90th Annual Meeting of the German Society of Cardiology - Cardiovascular Research (DGK). The DGK Annual Meeting took place from 3 to 6 April 2024 in Mannheim.

An international group of experts published recommendations for improving the treatment of atrial fibrillation. The position paper summarises the results of the 9th AFNET/EHRA Consensus Conference - a two-day expert meeting jointly hosted by the Atrial Fibrillation Network...

Catheter-based aortic valve replacement is on a par with surgical aortic valve replacement, even in younger low-risk patients. This is the result of the one-year evaluation of the DEDICATE-DZHK6 study, which was conducted under the direction of Prof. Dr Stefan Blankenberg at the...

Hier finden Sie eine Auswahl an Programmpunkten, an denen das DZHK beteilgt ist. Außerdem freuen wir uns, Sie wieder am DZHK-Stand (gleich neben der Medienannahme) begrüßen zu dürfen.

Leading mid-career researchers in Germany, the Netherlands and the UK will join forces to drive breakthroughs in the detection, diagnosis and treatment of heart and circulatory diseases, thanks to a pioneering partnership between the British Heart Foundation (BHF), Dutch Heart...

In clinical trials, new therapies or drugs are tested on a large number of patients or healthy volunteers: Nothing works without biometrics. This is because studies have to be statistically planned, systematically checked and carefully analysed. This is Tim Friede's speciality:...

Unique in the world: laboratory-grown heart tissue has been implanted in patients with heart failure as part of a study conducted by the University Medical Center Göttingen (UMG) and the University Hospital Schleswig-Holstein (UKSH). The so-called heart patch is intended to...